Abiopharma

🔍 Short Bartie Wendy (Executive)

Company: BRISTOL MYERS SQUIBB CO (BMY)

Report Date: 2025-09-01

Detailed Transactions and Holdings:

• Acquired 1,235 shares of Common Stock, $0.10 par value (Direct)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,301.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 632 shares of Common Stock, $0.10 par value at $47.18 per share (Direct)
  Date: 2025-09-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,669.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 1,235 shares of Restricted Stock Units (Derivative)
  Date: 2025-09-01 | Code: M | Expires: 2026-09-01 | equity_swap_involved: 0 | shares_owned_after: 1,236.00 | transaction_form_type: 4 | Footnotes: F3, F1

Footnotes:

• F1: These restricted stock units vest in four equal installments beginning on September 1, 2023.
• F2: Shares withheld for payment of taxes upon vesting of awards.
• F3: Each restricted stock unit converts into one share of common stock upon vesting.